Éva Hellinger

Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood–brain barrier penetration models

Éva Hellinger, Szilvia Veszelka, Andrea E. Tóth et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2012 · 224 citations

Blood–brain Barrier, Vascular Biology, Brain Injury +6

Comparison of a Rat Primary Cell-Based Blood-Brain Barrier Model With Epithelial and Brain Endothelial Cell Lines: Gene Expression and Drug Transport

Szilvia Veszelka, András Tóth, Fruzsina R. Walter et al. · Frontiers in Molecular Neuroscience · 2018 · 127 citations · Full text

Bbb Models, Bbb Related Genes, Blood–brain Barrier +14

Sucrose Esters Increase Drug Penetration, But Do Not Inhibit P‐Glycoprotein in Caco‐2 Intestinal Epithelial Cells

Lóránd Kiss, Éva Hellinger, Ana‐Maria Pilbat et al. · Journal of Pharmaceutical Sciences · 2014 · 55 citations

Inhibit P‐glycoprotein, Biochemistry, Gastrointestinal Pharmacology +8

Docosahexaenoic Acid Reduces Amyloid-β Induced Toxicity in Cells of the Neurovascular Unit

Szilvia Veszelka, Andrea E. Tóth, Fruzsina R. Walter et al. · Journal of Alzheimer s Disease · 2013 · 49 citations

Drug penetration model of vinblastine-treated Caco-2 cultures

Éva Hellinger, Mónika Laura Bakk, Péter Pócza et al. · European Journal of Pharmaceutical Sciences · 2010 · 48 citations

Pharmaceutical Science, Drug Resistance, Medicine +6